Literature DB >> 28331760

Partial-Breast Irradiation - Current Situation with Evidence.

Hale Başak Çağlar1.   

Abstract

Year:  2017        PMID： 28331760      PMCID： PMC5351457          DOI： 10.5152/tjbh.2016.3338

Source DB:  PubMed          Journal:  J Breast Health        ISSN： 1306-0945


× No keyword cloud information.
  27 in total

1.  Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial.

Authors:  Saskia Litière; Gustavo Werutsky; Ian S Fentiman; Emiel Rutgers; Marie-Rose Christiaens; Erik Van Limbergen; Margreet H A Baaijens; Jan Bogaerts; Harry Bartelink
Journal:  Lancet Oncol       Date:  2012-02-27       Impact factor: 41.316

2.  Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009).

Authors:  Csaba Polgár; Erik Van Limbergen; Richard Pötter; György Kovács; Alfredo Polo; Jaroslaw Lyczek; Guido Hildebrandt; Peter Niehoff; Jose Luis Guinot; Ferran Guedea; Bengt Johansson; Oliver J Ott; Tibor Major; Vratislav Strnad
Journal:  Radiother Oncol       Date:  2010-02-22       Impact factor: 6.280

3.  10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial.

Authors:  G Liljegren; L Holmberg; J Bergh; A Lindgren; L Tabár; H Nordgren; H O Adami
Journal:  J Clin Oncol       Date:  1999-08       Impact factor: 44.544

4.  Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer.

Authors:  T A King; J S Bolton; R R Kuske; G M Fuhrman; T G Scroggins; X Z Jiang
Journal:  Am J Surg       Date:  2000-10       Impact factor: 2.565

5.  Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement.

Authors:  Candace Correa; Eleanor E Harris; Maria Cristina Leonardi; Benjamin D Smith; Alphonse G Taghian; Alastair M Thompson; Julia White; Jay R Harris
Journal:  Pract Radiat Oncol       Date:  2016-09-17

6.  The American Brachytherapy Society consensus statement for accelerated partial breast irradiation.

Authors:  Chirag Shah; Frank Vicini; David E Wazer; Douglas Arthur; Rakesh R Patel
Journal:  Brachytherapy       Date:  2013-04-23       Impact factor: 2.362

7.  Limited-field radiation therapy in the management of early-stage breast cancer.

Authors:  Frank A Vicini; Larry Kestin; Peter Chen; Pamela Benitez; Neal S Goldstein; Alvaro Martinez
Journal:  J Natl Cancer Inst       Date:  2003-08-20       Impact factor: 13.506

8.  Radiation therapy of early carcinoma of the breast without mastectomy.

Authors:  S Hellman; J R Harris; M B Levene
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

9.  Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer.

Authors:  R M Clark; P B McCulloch; M N Levine; M Lipa; R H Wilkinson; L J Mahoney; V R Basrur; B D Nair; R S McDermot; C S Wong
Journal:  J Natl Cancer Inst       Date:  1992-05-06       Impact factor: 13.506

10.  Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.

Authors:  Jayant S Vaidya; Frederik Wenz; Max Bulsara; Jeffrey S Tobias; David J Joseph; Mohammed Keshtgar; Henrik L Flyger; Samuele Massarut; Michael Alvarado; Christobel Saunders; Wolfgang Eiermann; Marinos Metaxas; Elena Sperk; Marc Sütterlin; Douglas Brown; Laura Esserman; Mario Roncadin; Alastair Thompson; John A Dewar; Helle M R Holtveg; Steffi Pigorsch; Mary Falzon; Eleanor Harris; April Matthews; Chris Brew-Graves; Ingrid Potyka; Tammy Corica; Norman R Williams; Michael Baum
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.